1AI 10.0% 0.9¢ algorae pharmaceuticals limited

Ann: Results of LCT Parkinsons trial require further analysis, page-51

  1. 145 Posts.
    lightbulb Created with Sketch. 16
    I agree KraDen. I think the results need to be unpacked. I am hoping that in the unpacking, a better perspective is offered. Not selling at ridiculously low levels. In for long haul because they have proven products...that need more refinement and development. Still a paradigm changer.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.